Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Quantifying the waning of humoral immunity

View through CrossRef
AbstractImmunological memory is a defining feature of immunity, yet surprisingly there is no consensus on how to quantitatively describe how antibody titers wane over time. A major problem is that the slow waning of antibody titers requires the collection of data for decades post-infection or vaccination. Our analysis of the largest existing dataset shows that a power-law model describes antibody waning better than other frequently used models. Our analysis suggests: (i) Protective levels of antibodies to many vaccine/virus antigens may be maintained for longer than previously estimated. (ii) The rate of waning of antibodies to protein toxoid vaccines such as tetanus may be similar to those elicited by live virus infections. (iii) The long-term waning of antibodies can be estimated from data for a much shorter time-frame of about 1-3 years following immunization, suggesting that using a power-law analysis could allow rapid estimation for the waning of immunity to new vaccines.
Title: Quantifying the waning of humoral immunity
Description:
AbstractImmunological memory is a defining feature of immunity, yet surprisingly there is no consensus on how to quantitatively describe how antibody titers wane over time.
A major problem is that the slow waning of antibody titers requires the collection of data for decades post-infection or vaccination.
Our analysis of the largest existing dataset shows that a power-law model describes antibody waning better than other frequently used models.
Our analysis suggests: (i) Protective levels of antibodies to many vaccine/virus antigens may be maintained for longer than previously estimated.
(ii) The rate of waning of antibodies to protein toxoid vaccines such as tetanus may be similar to those elicited by live virus infections.
(iii) The long-term waning of antibodies can be estimated from data for a much shorter time-frame of about 1-3 years following immunization, suggesting that using a power-law analysis could allow rapid estimation for the waning of immunity to new vaccines.

Related Results

Post-pandemic modeling of COVID-19: Waning immunity determines recurrence frequency
Post-pandemic modeling of COVID-19: Waning immunity determines recurrence frequency
AbstractThere are many factors in the current phase of the COVID-19 pandemic that signal the need for new modeling ideas. In fact, most traditional infectious disease models do not...
An analysis of the waning effect of COVID-19 vaccinations
An analysis of the waning effect of COVID-19 vaccinations
Vaccine development is one of the key efforts to control the spread of coronavirus disease 2019 (COVID-19). However, it has become apparent that the immunity acquired through vacci...
IMMU-14. MENINGEAL PLASMA CELLS MOUNT AN IMMUNOLOGICAL DEFENSE AGAINST GLIOBLASTOMA
IMMU-14. MENINGEAL PLASMA CELLS MOUNT AN IMMUNOLOGICAL DEFENSE AGAINST GLIOBLASTOMA
Abstract INTRODUCTION: Glioblastoma (GBM) represents the deadliest primary intracranial neoplasm. While many studies have focused on T cell responses to GBM, few hav...
Covid-19: Natural Immunity Versus Vaccine Immunity Abstract
Covid-19: Natural Immunity Versus Vaccine Immunity Abstract
It should not be necessary to write an article to demonstrate the superiority of natural immunity over vaccine immunity, but it is necessary in view of the many underhanded attacks...
Covid-19 : Natural immunity versus vaccine immunity
Covid-19 : Natural immunity versus vaccine immunity
It should not be necessary to write an article to demonstrate the superiority of natural immunity over vaccine immunity, but it is necessary in view of the many underhanded attacks...
Assessment of SARS-CoV-2 immunity in convalescent children and adolescents
Assessment of SARS-CoV-2 immunity in convalescent children and adolescents
Background: Persistence of protective immunity for SARS-CoV-2 is important against reinfection. Knowledge on SARS-CoV-2 immunity in pediatric patients is currently lacking. We opte...

Back to Top